Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3899 of 6351
-
Can a common plant compound help rare telomere disease?
Symptom relief Recruiting nowThe purpose of this study is to see if a vitamin-like substance called quercetin is safe for people who have a rare condition called Dyskeratosis congenita (DC) or telomere biology disorders (TBD).
Phase 1 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
No software needed: new study seeks to classify cavovarus feet by simple exam
Knowledge-focused Recruiting nowCavovarus feet are complex deformities in multiple planes. There is little consensus on the best way to address deformities. Furthermore there are various different phenotypes and we have previously described 4 distinct forefoot morphotypes that exist. It has been hypothesised th…
Sponsor: Royal National Orthopaedic Hospital NHS Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
AI watches hospital Patients' vital signs to catch decline early
Knowledge-focused Not yet recruitingThe ONWARD study evaluates user experiences from continuous vital sign monitoring alarms sent to the clinical staff in case of deviating vital signs at the general hospital ward. User experiences are evaluated though a 5-point likert questionnaire.
Sponsor: Eske Kvanner Aasvang • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Remote coaching may match In-Person training for medical skills
Knowledge-focused Recruiting nowThe goal of this study is to evaluate whether remote asynchronous feedback is non-inferior to direct synchronous feedback during simulation-based training for ultrasound-guided popliteal sciatic nerve block performance. The main questions it aims to answer are: Does asynchronous…
Sponsor: Pontificia Universidad Catolica de Chile • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Can CF drugs tame diabetes in cystic fibrosis?
Knowledge-focused By invitation onlyThe study aims to test whether use of CFTR modulators (ETI) improves fasting and post prandial glycemia by enhancing disposition index (DI) in individuals with CFRD with CFTR +ve mutation (at least one copy of F508del) on CFTR modulator (ETI) therapy (CFRDF508del+ETI). CFRD with …
Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
New workplace program aims to lift depression and get hospital workers moving
Symptom relief Recruiting nowThis study develops and tests a dynamic workplace-based depression intervention that is tailored to the specific social and behavioral needs of low-wage hospital service workers. The intervention involves assessment of depression-related work impairment, work-focused cognitive be…
Sponsor: San Diego State University • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Stress and your cycle: new study investigates the link
Knowledge-focused Recruiting nowThe goal of this experimental study is to determine how stressors that do not directly impact energy state or energy demands (hereafter called "non-energetic stressors") affect reproductive health in pre-menopausal women. It aims to do this by answering the following main questio…
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Sep 10, 2026 01:00 UTC
-
Community health check: can better care improve lives?
Knowledge-focused Recruiting nowBased on the Danish Health Authority's quality standards for municipal prevention services for citizens with chronic diseases, Steno Diabetes Center Copenhagen (SDCC), Halsnaes Municipality, North Zealand Hospital, and others have entered into a cross-sectoral collaboration entit…
Sponsor: Steno Diabetes Center Copenhagen • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Can a second pill stop your migraine? new study investigates
Symptom relief Recruiting nowAcute treatments for migraine may not provide sufficient pain relief after an initial dose, and a second dose of a given medication may be needed to fully abort an attack. International Headache Society (IHS) global practice recommendations for the Acute Treatment of Migraine sug…
Phase 4 • Sponsor: Pfizer • Aim: Symptom relief
Last updated Aug 26, 2026 00:00 UTC
-
New drug ABBV-519 enters first human tests for lupus and arthritis
Disease control Recruiting nowSystemic lupus erythematosus (SLE) is a chronic, systemic autoimmune disease characterized by B cell hyperactivity. Rheumatoid Arthritis (RA) is a chronic inflammatory disease causing pain, stiffness, swelling and loss of joint function. The purpose of this study is to assess th…
Phase 1 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New drug LYNC-101 enters first human trials for ulcerative colitis
Disease control By invitation onlyThis Phase I study is designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), immunogenicity, and cytokine profiles of LYNC-101 for Injection in healthy adult participants. The study consists of 2 parts: Part 1 is a single ascending dose (SAD)…
Phase 1 • Sponsor: LyncBio Therapeutics Co., Ltd. • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Electric zaps to breathing muscles may speed heart recovery
Symptom relief Not yet recruitingThis study is a randomized controlled trial designed to evaluate the effects of combined diaphragmatic and abdominal neuromuscular electrical stimulation (NMES) on arterial blood gases, pulmonary function, left ventricular ejection fraction, and functional capacity in patients fo…
Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Memory boost for cocaine users? small study tests potassium channel blocker
Knowledge-focused Recruiting nowThe study aims to address the neurobiological basis of cognitive impairments in chronic cocaine users by investigating the potential impact of an acute potassium channel blockade on working memory performance and other cognitive functions.
Sponsor: Boris Quednow • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
Could a simple gel soothe heartburn without drugs? new trial aims to find out
Symptom relief Recruiting nowThe goal of this randomized, double-blind, single-center clinical trial RELEIF is to learn if medical devices work to decrease symptoms of gastroesophageal reflux disease (GERD) in adults' patients. It will also teach us about safety, tolerability and improvement of patient's qua…
Sponsor: Cellmedis • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
New program aims to ease burden on heart failure caregivers
Symptom relief Recruiting nowThis RCT design will enroll 256 informal caregivers (spouse/partner or child) of HHC patients with HF/CI and 60 patients with HF and mild to moderate CI (60 dyads). After collecting baseline data, we will block randomize the caregivers 1:1 to the ViCCY intervention or comparator …
Sponsor: Visiting Nurse Service of New York • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
New dashboard aims to give surgeons a complete view during heart surgery
Knowledge-focused Recruiting nowHEMO-INTEGRA is a software system that integrates four domains of intraoperative hemodynamic monitoring in a single dashboard during cardiac surgery with cardiopulmonary bypass (CPB): (1) ventricular-arterial coupling (VAC) analysis using the Balan 2026 method; (2) tissue perfusi…
Sponsor: Hernán Darío Castro Arias • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
New eczema drug HXN5003 enters first human safety trial
Symptom relief Not yet recruitingThe goal of this intervention study is to evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of HXN5003 in Healthy Participants.The main parameters it aims to answer are: 1. Does a single dose of HXN5003 in healthy participants impact the safety, tolerability …
Phase 1 • Sponsor: Helixon Biotechnology (Suzhou) Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New VR device aims to make exercise fun for kids with muscle weakness
Symptom relief Recruiting nowSpinal muscular atrophy is a genetic disorder characterized by progressive muscle weakness, severely impacting patients' motor abilities. Several disease modifying therapies have been developed to treat Spinal muscular atrophy which have led to new disease trajectories . Accordin…
Sponsor: University of Oxford • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
New study tests if injecting drug into bone works better than IV during joint replacement
Knowledge-focused Not yet recruitingThis prospective randomized controlled trial aims to compare the pharmacokinetic profiles of intraosseous and intravenous tranexamic acid administration in patients undergoing primary total joint arthroplasty. Eligible patients undergoing total hip or total knee arthroplasty will…
Phase 4 • Sponsor: Hua Luo • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Ice pack showdown: can a cooling cuff beat the classic bag of ice after knee surgery?
Symptom relief Recruiting nowTopic/Disease Pattern Postoperative pain and swelling management after knee prosthesis implantation using cryotherapy Objective To determine possible differences in postoperative swelling and pain following primary total knee arthroplasty (TKA) under cryotherapy using cuff cooli…
Sponsor: Prof. Dr. med. Andreas Halder • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC